Report: Egypt Delivers 1 M. Locally Manufactured Sinovac Doses

Egypt is considered one of the earliest countries in the world that decided to manufacture the Chinese Sinovac vaccine after setting an agreement with China.

The deal was inked between the Chinese Embassy in Cairo, Sinovac cooperation, and Vacsera at the headquarter of the Egyptian cabinet in April.

Therefore, the state started producing the vaccine with the participation of Chinese experts. The locally manufactured vaccine went into a strict process of evaluation- 11 tests before it was approved.

Also, the early production of the vaccine went into eight-week studies to be compared to the original production of China.

Finally, Egypt succeeded in delivering the first one million locally manufactured Sinovac doses according to the agreement signed between Sinovac and Vacsera. They were distributed to all vaccination centers in Egypt as Sinovac was approved for emergency use on August 23.

Moreover, Sinovac approved its safety and effectiveness against Coronavirus based on the standards of the World Health Organization.

It is worthy to mention that Sinovac provided all required raw materials to Vacsera for manufacturing the vaccine in Egypt.

In addition, the Chinese experts trained medical teams and workers in the Egyptian corporation to empower them to deal with the Chinese vaccine as part of the Egyptian-Chinese agreement.

Currently, there are 15 million vaccine doses in the process of production and evaluation to be distributed to the vaccination centers in Egypt.

Furthermore, Vacsera is working on localizing the production of eight vaccines for several diseases such as pentavalent vaccine (5-in-1), Hepatitis B for newborn children and for adults, TD, DPT, Tetanus toxoid, MMR, and MR.